Works by Lavie, David


Results: 20
    1

    Thrombocytopenic Myelofibrosis (MF) Patients Previously Treated with a JAK Inhibitor in a Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) (MOMENTUM).

    Published in:
    Journal of Oncology Navigation & Survivorship, 2022, v. 13, n. 11, p. 388
    By:
    • Gerds, Aaron;
    • Verstovsek, Srdan;
    • Vannucchi, Alessandro;
    • Al-Ali, Haifa Kathrin;
    • Lavie, David;
    • Kuykendall, Andrew;
    • Grosicki, Sebastian;
    • Iurlo, Alessandra;
    • Goh, Yeow Tee;
    • Lazaroiu, Mihaela;
    • Egyed, Miklos;
    • Fox, Maria Laura;
    • McLornan, Donal;
    • Perkins, Andrew;
    • Sung-Soo Yoon;
    • Gupta, Vikas;
    • Kiladjian, Jean-Jacques;
    • Donahue, Rafe;
    • Kawashima, Jun;
    • Mesa, Ruben
    Publication type:
    Article
    2

    MOMENTUM: Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) in Symptomatic and Anemic Myelofibrosis (MF) Patients Previously Treated with a JAK Inhibitor.

    Published in:
    Journal of Oncology Navigation & Survivorship, 2022, v. 13, n. 11, p. 377
    By:
    • Mesa, Ruben;
    • Gerds, Aaron;
    • Vannucchi, Alessandro;
    • Al-Ali, Haifa Kathrin;
    • Lavie, David;
    • Kuykendall, Andrew;
    • Grosicki, Sebastian;
    • Iurlo, Alessandra;
    • Yeow Tee Goh;
    • Lazaroiu, Mihaela;
    • Egyed, Miklos;
    • Fox, Maria Laura;
    • McLornan, Donal;
    • Perkins, Andrew;
    • Sung-Soo Yoon;
    • Gupta, Vikas;
    • Kiladjian, Jean-Jacques;
    • Donahue, Rafe;
    • Kawashima, Jun;
    • Verstovsek, Srdan
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Risk factors and outcomes of COVID‐19 in adult patients with hematological malignancies: A single‐center study showing lower than expected rates of hospitalization and mortality.

    Published in:
    European Journal of Haematology, 2023, v. 111, n. 1, p. 135, doi. 10.1111/ejh.13977
    By:
    • Aumann, Shlomzion;
    • Tsubary, Uria;
    • Nachmias, Boaz;
    • Ben Yehuda, Dina;
    • Lavie, David;
    • Goldschmidt, Neta;
    • Vainstein, Vladimir;
    • Libster, Diana;
    • Saban, Revital;
    • Shaulov, Adir;
    • Israel, Sarah;
    • Avni, Batia;
    • Grisariu, Sigal;
    • Bdolah‐Amram, Tali;
    • Gatt, Moshe;
    • Zimran, Eran
    Publication type:
    Article
    15

    Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/ CT is beneficial: a prospective multicentre trial of 355 patients.

    Published in:
    British Journal of Haematology, 2017, v. 178, n. 5, p. 709, doi. 10.1111/bjh.14734
    By:
    • Dann, Eldad J.;
    • Bairey, Osnat;
    • Bar‐Shalom, Rachel;
    • Mashiach, Tanya;
    • Barzilai, Elinor;
    • Kornberg, Abraham;
    • Akria, Luiza;
    • Tadmor, Tamar;
    • Filanovsky, Kalman;
    • Abadi, Uri;
    • Kagna, Olga;
    • Ruchlemer, Rosa;
    • Abdah‐Bortnyak, Roxolyana;
    • Goldschmidt, Neta;
    • Epelbaum, Ron;
    • Horowitz, Netanel A.;
    • Lavie, David;
    • Ben‐Yehuda, Dina;
    • Shpilberg, Ofer;
    • Paltiel, Ora
    Publication type:
    Article
    16
    17
    18

    Hypericin as an Antiretroviral Agent.

    Published in:
    Annals of the New York Academy of Sciences, 1991, v. 616, n. 1, p. 556, doi. 10.1111/j.1749-6632.1990.tb17893.x
    By:
    • LAVIE, GAD;
    • MAZUR, YEHUDA;
    • LAVIE, DAVID;
    • LEVIN, BRANDI;
    • ITTAH, YITZHAK;
    • MERUELO, DANIEL
    Publication type:
    Article
    19
    20